Company intelligence / Profile preview

Ludocare

Ecully/Lyon, Auvergne-Rhône-Alpes, Franceludocare.com ↗

Ownership: Private
Employees: ~9
Development stage: Other

Overview

Ludocare’s flagship product, the JOE digital therapeutic, has demonstrated clinical effectiveness in a randomized phase 3 trial involving 213 children aged 4–11 with persistent asthma. The study showed that use of JOE significantly reduced the number of severe asthma attacks among children aged 7–11. The solution is available by prescription and aims to improve medication adherence and disease control through interactive engagement

Therapeutic areas: Pulmonology
Modalities: DeviceDigital therapeutic (DTx)Non-pharmacological therapy (digital behavioral intervention)
Industry: Digital Health Medical Devices

Partnerships

Benkei (innovation strategy support)Karista (investor/partner)Bpifrance (investor/partner)

Beyond the preview

Go deeper on Ludocare.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Ludocare.

Explore the full profile